Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Magnusson

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
The American Journal of Physiology|August 13, 1999
Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cellsT Gustafsson, P Andersson, Y Chen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1994
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brainH Hall, G Sedvall, O Magnusson, et al.
European Journal of Pharmacology|April 29, 1986
The effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phospholipid breakdown in rat hippocampal miniprismsC J Fowler, O Magnusson, A K Mohammed, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 1, 1984
Comparison of an elemental and two polymeric diets in colectomized patients with or without intestinal resectionH Andersson, I Bosaeus, L Ellegard, et al.
Urology|December 1, 1974
Renal transplantation. III. Prevention of wound infectionsL H Banowsky, J E Montie, W E Braun, et al.
Neuropharmacology|April 1, 1987
Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonistC J Fowler, O Magnusson, G Thorell, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Comparison of two methods of kinetic modelingP W Ellis, P S Malchesky, M O Magnusson, et al.
Acta Pharmaceutica Suecica|January 1, 1978
Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compoundsS Gronowitz, M Herslöf, R Svenson, et al.
Acta Pharmaceutica Suecica|January 1, 1978
Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acidsS Gronowitz, M Herslöf, R Svenson, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxinM O Magnusson, M-L Dahl, J Cederberg, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
The American Journal of Physiology|August 13, 1999
Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cellsT Gustafsson, P Andersson, Y Chen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1994
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brainH Hall, G Sedvall, O Magnusson, et al.
European Journal of Pharmacology|April 29, 1986
The effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phospholipid breakdown in rat hippocampal miniprismsC J Fowler, O Magnusson, A K Mohammed, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 1, 1984
Comparison of an elemental and two polymeric diets in colectomized patients with or without intestinal resectionH Andersson, I Bosaeus, L Ellegard, et al.
Urology|December 1, 1974
Renal transplantation. III. Prevention of wound infectionsL H Banowsky, J E Montie, W E Braun, et al.
Neuropharmacology|April 1, 1987
Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonistC J Fowler, O Magnusson, G Thorell, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Comparison of two methods of kinetic modelingP W Ellis, P S Malchesky, M O Magnusson, et al.
Acta Pharmaceutica Suecica|January 1, 1978
Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compoundsS Gronowitz, M Herslöf, R Svenson, et al.
Acta Pharmaceutica Suecica|January 1, 1978
Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acidsS Gronowitz, M Herslöf, R Svenson, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxinM O Magnusson, M-L Dahl, J Cederberg, et al.
Pageof 16